Navigation Links
HLT Announces First Patient Enrollments in a Feasibility Study of a New Transcatheter Aortic Valve Replacement System
Date:4/4/2017

MINNEAPOLIS, April 4, 2017 /PRNewswire/ -- HLT, Inc., today announced first patient implants in a Feasibility Clinical study to assess the safety and performance outcomes of its Meridian® Transcatheter Aortic Valve and Pathfinder® II Delivery System in patients with severe aortic stenosis at high risk for surgery. 

Meridian Valve
Meridian Valve

The implants were completed at Quebec Heart and Lung Institute in Quebec City, Canada, by Josep Rodés-Cabau, M.D., and his team.

"The Meridian® Valve allows us to evaluate complete valve function before releasing it from the delivery system," said Dr. Rodés-Cabau, director of Catheterization and Interventional Laboratories at the Quebec Heart and Lung Institute (Quebec City, Quebec, Canada). "The valve was easy to implant and the overall procedure was predictable. Hemodynamic stability was maintained throughout the entire procedure, including the time of valve implant." For more information about the Meridian® Valve, please visit www.hltmedical.com.

The RADIANT trial is a prospective, non-randomized, single-arm, multicenter study that will enroll up to 20 high-risk patients with severe aortic valve stenosis. The endpoint will evaluate all-cause mortality at 30 days after implant of the Meridian® Transcatheter Aortic Valve. Patient follow-up will occur at one, six and 12 months and annually to five years.    

"The RADIANT clinical study will provide evidence regarding the safety and performance of a third-generation transcatheter aortic valve replacement therapy," said Kevin Bassett, HLT general manager. "We're delighted to partner in the study with outstanding clinicians at the Quebec Heart and Lung Institute as well as the Sunnybrook Health Science Centre in Toronto."

An estimated 1.5 million patients in North America and Europe suffer from severe aortic stenosis, according to Osnabrugge. The standard treatment is surgical valve replacement, which involves an open-heart operation. But an estimated 30 percent of patients with severe aortic stenosis are considered too weak or sick to undergo successful open-heart surgery.

Transcatheter aortic valve replacement (TAVR) therapy is a less invasive option for these patients. During a TAVR procedure, a compressed replacement valve is delivered via a catheter, or long, hollow tube, placed in a blood vessel in the upper leg and threaded to the beating heart. The physician positions and delivers the replacement valve inside the damaged valve then removes the catheter.

HLT's Meridian® Transcatheter Valve is self-expanding. As in surgical valve designs, a flexible wire frame supports the valve's leaflets which is designed to promote good flow characteristics and reduce stress on the leaflet tissue for long-term performance.

Physicians treating patients with transcatheter valve therapy settle for less-than-ideal valve positioning in up to 25 percent of cases. Ideal positioning helps achieve good hemodynamics (blood flow and pressure), reduces leakage around the valve's base and contributes to optimal patient outcomes.

HLT's Pathfinder® delivery system is intended to provide physicians confidence in positioning the valve. Specifically, it is designed to allow them to reposition or retrieve the valve if necessary and most importantly fully assess the valve's function prior to its final release in the heart.

About HLT
HLT, Inc., is a clinical phase medical device company focused on transcatheter aortic valve replacement therapy that will provide physicians increased procedure confidence, control during the implant procedure and improved patient outcomes. HLT's Meridian® Transcatheter Aortic Valve is designed to conform to the natural structure of the heart, and its Pathfinder® II Delivery System provides physicians control over valve placement in a beating heart, as well as flexibility to reposition or fully retrieve the valve before release.

HLT is headquartered in Maple Grove, Minn. Its team of 90 employees works alongside its sister company ACIST Medical Systems, a pioneer and market leader of advanced contrast delivery and imaging systems for interventional cardiology. The privately held companies are part of the Bracco Group, an international leader in diagnostic imaging based in Milan, Italy. For more about HLT, visit www.hltmedical.com.

About Bracco Group
Bracco has headquarters in Milan, Italy, and was founded in 1927. It is active in the healthcare sector through Bracco Imaging (diagnostic imaging), ACIST Medical Systems and HLT (cardiology) and the Centro Diagnostico Italiano diagnostic clinic. It has around 3,400 employees and annual total consolidated revenues of over $1.38 billion USD (1.3 billion Euro). Bracco operates in more than 100 countries worldwide. To learn more about Bracco Group, visit www.bracco.com.

Osnabrugge R., et al Aortic Stenosis in the Elderly. J Am Coll Card 2013; 62:1002-12

For Investigational Use Only. Not Available for Sale in Any Geography.

Contact: Peggy Malikowski
763-416-7511
Peggy.Malikowski@hltmedical.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hlt-announces-first-patient-enrollments-in-a-feasibility-study-of-a-new-transcatheter-aortic-valve-replacement-system-300433920.html


'/>"/>
SOURCE HLT, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Therapix Biosciences Ltd. Announces Full Exercise of Underwriters Over-Allotment Option
2. Minnesota Medical Announces David A. Jonas as Chief Financial Officer/Director
3. Versartis Announces Three Year Somavaratan Data at ENDO 2017 Showing Safety and Efficacy in Line with Historical U.S. Daily rhGH Data in Pediatric GHD
4. International Isotopes Inc. Announces 2016 Year End Financial Results
5. Ascendis Pharma A/S Announces Updated Time for April 3 Conference Call to Review ENDO 2017 Data
6. CytoSorbents Announces Proposed Offering of Common Stock
7. DarioHealth Corp. Announces Proposed Public Offering of Common Stock
8. Boston Scientific Announces Agreement to Acquire Symetis
9. Novartis announces first CAR-T cell therapy BLA for pediatric and young adult patients with r/r B-cell ALL granted FDA Priority Review
10. Medeon Biodesign Announces Investing in Panther Orthopedics for Orthopedic Extremity Applications
11. EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Kitov Pharmaceutical Holdings Ltd. - KTOV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... 22, 2017  As the latest Obamacare repeal effort ... Cassidy (R-LA) and Lindsey Graham (R-SC) ... medical device industry is in an odd place.  The ... 2.3% excise tax on medical device sales passed along ... covered patients, increased visits and hospital customers with the ...
(Date:9/19/2017)...   ZirMed Inc ., a recognized leader in cloud-based ... has been ranked #1 by its users for the seventh ... User Survey. ZirMed was recognized as the top-ranked end-to-end revenue ... centers over 200 beds and holds one of the longest ... history. ...
(Date:9/13/2017)... 2017   OrthoAtlanta has been named the official ... Committee (AFHC) for the 2018 College Football Playoff (CFP) National ... Mercedes-Benz Stadium in Atlanta, Georgia . OrthoAtlanta ... In" campaign, participating in many activities leading up to, and ... ...
Breaking Medicine Technology:
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... 12, 2017 , ... Women-owned and Grand Rapids-based workplace wellness ... in Wellness® by Best and Brightest. OnSite Wellness will be honored at the ... 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located at ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, ... In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the ... have extremely low property-tax rates, which contributes to the relatively lower cost of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm ... California Berkeley, and other leading institutions in announcing the launch of the ... change the way animals are raised for food. , Founding members of the ...
(Date:10/12/2017)... ... 12, 2017 , ... Nvision Biomedical Technologies , a ... addition of industry sales leader, Thomas (Tom) Slott, as Senior Vice President of ... sales network, direct the efforts of the surgical sales teams, manage contractual agreements, ...
Breaking Medicine News(10 mins):